Effect of Palm and LI4 (Hegu) Acupressure on Labor Pain, Labor Duration and Satisfaction

November 9, 2026 updated by: Emine Tekeli

The Effect of Palm and LI4 Acupressure Applications During Labor on Labor Pain, Duration and Satisfaction: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of palm (hand point) pressure and LI4 (Hegu) acupressure applied during labor on labor pain, duration of labor, and maternal birth satisfaction. A total of 105 nulliparous women aged 18-35 years with a term, low-risk, singleton pregnancy in spontaneous labor will be randomly assigned to three groups of 35: a palm pressure group, an LI4 acupressure group, and a control group receiving routine labor care. In the palm group, women press a wooden comb into their own palm during contractions. In the LI4 group, the researcher applies pressure to the LI4 point during contractions using an Electronic Acupuncture Pen and Meridian Massage Device. Applications are performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Pain is measured with a Visual Analog Scale and an observer-rated pain expression scale (ESVADOPA) before and 30 minutes after each application. Duration of labor and neonatal Apgar scores are recorded, and birth satisfaction is assessed within 4 hours after birth. The study is conducted in a single center in Gaziantep, Türkiye.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

105

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Aged 18-35 years
  • Able to read, write and understand Turkish
  • Nulliparous woman with a term pregnancy (37-42 weeks of gestation)
  • Singleton, live fetus in vertex presentation
  • Spontaneous onset of labor
  • Cervical dilatation of 4 cm or more
  • Estimated fetal weight of 2500-4000 g confirmed by ultrasound by a physician
  • No risk factors in obstetric and medical history (low-risk pregnancy)
  • Willing to participate and gives written informed consent

Exclusion Criteria:

  • Multiple pregnancy
  • Pregnancy achieved by in vitro fertilization (IVF)
  • Complicated pregnancy (e.g., gestational diabetes, hypertensive disorders)
  • Previous cesarean delivery
  • Presentation anomaly
  • Induction of labor
  • Neurological, psychiatric or communication-impairing disease
  • Use of, or planned use of, another pain-relief method (e.g., hot/cold application, TENS, aromatherapy, massage)
  • Structural or chromosomal fetal anomaly
  • Obesity according to the World Health Organization classification (BMI 30 kg/m2 or higher)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Palm Pressure Group

Women apply pressure with a curved wooden comb to their own palm (Lao Gong point) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, under the supervision of the researcher. Routine labor care continues.

Palm Pressure Group:

A curved wooden comb is pressed by the woman into her own palm (Lao Gong point) during contractions. After the researcher demonstrates the technique, pressure is applied for six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

Other Names:
  • Hand point comb
  • LI4 pressure
Experimental: LI4 Acupressure Group

The researcher locates the LI4 (Hegu) point with an Electronic Acupuncture Pen and Meridian Massage Device and applies pressure (about 3-5 kg of force) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Routine labor care continues.

The researcher locates the LI4 (Hegu) point on the back of the hand with an Electronic Acupuncture Pen and Meridian Massage Device, which signals the point by light and sound. Pressure (about 3-5 kg of force) is then applied with the device. The application is performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

No Intervention: Control Group

Women receive routine midwifery care in the delivery room with no additional intervention. Pain measurements are made at the same dilatation stages as in the other groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Labor pain intensity measured by Visual Analog Scale (VAS)
Time Frame: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Women rate the pain felt after a contraction on a vertical Visual Analog Scale from 0 (no pain) to 10 (severe pain). The mark is measured with a ruler and recorded as the pain score. Higher scores indicate more pain.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain expression measured by the Rating Scale of Pain Expression during Childbirth (ESVADOPA)
Time Frame: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

An independent observer who is unaware of group allocation rates pain expression during contractions with ESVADOPA. The scale has 6 items (facial muscles, body response, verbal response, restlessness, ability to relax, vegetative symptoms), each scored 0-3. Total scores range from 0 to 18; higher scores indicate more pain expression.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
Duration of labor
Time Frame: From admission to the delivery room until delivery of the placenta (during labor and birth)

Duration of labor stages calculated in minutes from times recorded on the labor follow-up form: admission to the delivery room, start and end of the second stage, and delivery of the placenta.

From admission to the delivery room until delivery of the placenta (during labor and birth)
Birth satisfaction measured by the Birth Satisfaction Scale
Time Frame: Within 4 hours after birth

Women complete the 10-item Birth Satisfaction Scale (Turkish version), rated on a 5-point Likert scale (0-4), with reverse scoring for 4 items. Total scores range from 0 to 40; higher scores indicate greater birth satisfaction.

Within 4 hours after birth
Neonatal Apgar score
Time Frame: 1 minute and 5 minutes after birth

Apgar scores of the newborn, recorded on the labor follow-up form. Scores range from 0 to 10; higher scores indicate a better condition of the newborn.

1 minute and 5 minutes after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 13, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

March 30, 2027

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2026/64

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe